Roldan earned undergraduate degrees in both Chemistry and Biochemistry from the University of Salamanca and a Master’s Degree in Molecular Biotechnology from the University of Barcelona. In order to find new diagnostic methods and therapeutic approaches to fight cancer, he decided to continue his education and study tumor metabolism, which led him to obtain a Ph.D. in Molecular Biology with a focus in cancer metabolomics from the University of Barcelona in 2014. Subsequently, he worked as a Post-Doc Researcher, Project Manager and Assistant Professor at the University of Barcelona.
During his years of experience in scientific research, Roldan acquired expertise not only in the molecular study of cancer and in many different biochemical analysis techniques, but also in setting up new methods and workflows, supervising junior scientists and coordinating both public and privately funded academic-industry collaborative projects.
Roldan joined MedSIR in 2017. Since then he has been appointed Manager in the Business Development department. Roldán is fluent in Spanish and English and enjoys practicing archery. He is also the father of two toddlers and longs for a proper night's rest.
Eloy obtained his bachelor’s degree in Biomedicine at the University of Barcelona. Shortly after, he carried out a master’s program in Biomedicine and Cancer Research at the Faculty of Medicine of the Hospital Clínic of Barcelona.
At the end of his bachelor's, he performed a one-year internship at the Netherlands Cancer Institute (NKI) in Amsterdam. His research activity was mainly focused on the study of the sensitivity of several molecular inhibitors in combination with the standard of care treatment in Glioblastoma. As part of his master’s internship, Eloy collaborated with a prestigious research group at the Josep Carreras Leukaemia Foundation in Barcelona, dedicated to find new therapies for Leukaemia. He studied the depletion of cancer stem cells in leukemia using Bromocriptine, a dopamine agonist used to treat pituitary tumors and other diseases such as Parkinson.
In 2014, he received his master’s degree and shortly thereafter, he relocated to the Netherlands to commence a Ph.D. track under the supervision of prof. Marc Vooijs at the department of radiation oncology, Maastricht University. His research involved basic and therapeutic aspects of the HIF and NOTCH signaling pathways for cancer treatment. One of the most exciting achievements of his Ph.D. was the generation of several knock-out cell lines using the CRISPR/CAS9 technology for a set of different oncogenes.
Eloy joined MedSIR in 2019 as an International Network Specialist in the Business Development department where he works to help oncologists develop their ideas in various indications such as breast, prostate and genitourinary (GU) cancer. Also, he is in charge of building an international network of GU experts and establish direct relationships between the pharmaceutical/biotech industry and healthcare professionals.
Eloy speaks English, Spanish, Italian and Catalan fluently and has a working knowledge of Dutch. His main passion is traveling but he also enjoys a large set of activities such as CrossFit training, trekking, chess and hanging out with friends.
Isabel, MD, is a graduate of the University of Valencia Medical School. She trained in internal medicine and oncology at the Valencian Institute of Oncology in Spain and became board certified in Medical Oncology in 2006.
She took her position as a staff member at Provincial Hospital of Castellon in 2006 and continued her practice there for 11 years then gradually moved to the field of lung cancer and neuroendocrine tumors. For 15 years, during her fellowship and clinical practice, she held the position of Co-Investigator involved in phase 2 and 3 trials execution.
In 2009 she became certified as a Genetic Counsellor in Cancer Genetics and gradually focused on endocrine and NETs with special interest on hypoxia-driven syndromes.
In 2016 she was granted by the SEOM Foundation and was enrolled in the National Institutes of Health (NIH) as a Research Collaborator in January 2017. At NIH, she discovered the beauty of translational research and the passion for making ideas translate into clinical development.
In January 2019 she moved to MedSIR as a medical scientist in the scientific department, with the goal of impacting the lives of cancer patients through innovative clinical trials.
Isabel is fluent in English, Spanish and German. She is a dedicated mother of three and enjoys skiing, traveling and spending time with close friends.
Chiara graduated in Health Biotechnology at the University of Naples “Federico II”, Italy and earned her Master’s degree in Biomedical Sciences at the University of Florence, Italy. She then earned an International Ph.D. in Genomics of Male Infertility at the Fundació Puigvert in Barcelona, Spain. In 2015, Chiara received the IBSA Foundation Award in fertility for a project focused on the application of whole-exome sequencing to identify genomic alterations in infertile men.
In 2016, Chiara felt the urge to explore a different area of research and landed a job at the Cancer Genomics Group in the Vall d’Hebron Institute of Oncology (VHIO), where she earned broad knowledge of the technologies employed in the investigation of cancer genomes in the context of both clinical trials and basic research projects.
Driven by the interest in the business aspect of the healthcare sector, in 2018 Chiara started a full-time international MBA at EADA Business School and specialized in Structural Finance and Private Equity. After her graduation in July 2019, she attended an exchange program at the University of San Diego in California (USA) to learn more about sustainable business models in the frame of innovation.
In January 2020 Chiara joined MedSIR as International Network Specialist at Business Development Department.
As a reflection of her passion for multiculturalism, she loves traveling and fluently speaks English, Spanish, Catalan, German, as well as Italian. Author of several research articles and book chapters, Chiara enjoys writing and reading in her free time. And when she is not glued to a computer or a book, she joins outdoor activities and spoils her dog as much as possible.
Rui attended the University of Barcelona and graduated with a degree in Biomedical Sciences. She received her Master’s in Clinical Trials Monitoring at the International University Study Center. While obtaining her master’s, she supported several Breast Cancer trials at MedSIR as an intern where she gained an appreciation for the firm’s philosophy and innovative design.
Her Chinese background gives her a multicultural vision making her an enterprising and charismatic person with a future vision that refuses to settle down. She has a thirst for knowledge and always looking to grow her skill sets.
She speaks Spanish, Catalan, Chinese and English fluently.